Buscar
Oculis Holding AG
OCSAñadir a la lista de seguimiento
11.979USD
+0.669+5.92%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
703.03MCap. mercado
PérdidaP/E TTM
Más Datos de Oculis Holding AG Compañía
Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.
Información de Oculis Holding AG
Símbolo de cotizaciónOCS
Nombre de la empresaOculis Holding AG
Fecha de salida a bolsaMar 03, 2023
Director ejecutivoSherif (Riad)
Número de empleados49
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 03
DirecciónBahnhofstrasse 20
CiudadZUG
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísSwitzerland
Código postal6300
Teléfono41417113960
Sitio Webhttps://oculis.com/
Símbolo de cotizaciónOCS
Fecha de salida a bolsaMar 03, 2023
Director ejecutivoSherif (Riad)
Ejecutivos de Oculis Holding AG
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Martijn Kleijwegt
Mr. Martijn Kleijwegt
Independent Director
Independent Director
470.97K
--
Mr. Pall Ragnar Johannesson
Mr. Pall Ragnar Johannesson
Chief Business Officer
Chief Business Officer
288.43K
+6.80%
Mr. Lionel Carnot
Mr. Lionel Carnot
Independent Director
Independent Director
90.75K
--
Ms. Sylvia Cheung, CPA
Ms. Sylvia Cheung, CPA
Chief Financial Officer
Chief Financial Officer
77.32K
+6.80%
Ms. Geraldine O'Keeffe
Ms. Geraldine O'Keeffe
Independent Director
Independent Director
20.59K
--
Ms. Christina M. Ackermann
Ms. Christina M. Ackermann
Independent Director
Independent Director
6.53K
--
Dr. Riad Sherif, M.D.
Dr. Riad Sherif, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Anthony A. (Tony) Rosenberg
Mr. Anthony A. (Tony) Rosenberg
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Arshad M. Khanani, M.D.
Mr. Arshad M. Khanani, M.D.
Independent Director
Independent Director
--
--
Mr. Robert K. Warner
Mr. Robert K. Warner
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Martijn Kleijwegt
Mr. Martijn Kleijwegt
Independent Director
Independent Director
470.97K
--
Mr. Pall Ragnar Johannesson
Mr. Pall Ragnar Johannesson
Chief Business Officer
Chief Business Officer
288.43K
+6.80%
Mr. Lionel Carnot
Mr. Lionel Carnot
Independent Director
Independent Director
90.75K
--
Ms. Sylvia Cheung, CPA
Ms. Sylvia Cheung, CPA
Chief Financial Officer
Chief Financial Officer
77.32K
+6.80%
Ms. Geraldine O'Keeffe
Ms. Geraldine O'Keeffe
Independent Director
Independent Director
20.59K
--
Ms. Christina M. Ackermann
Ms. Christina M. Ackermann
Independent Director
Independent Director
6.53K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Oculis Holding AG?
Los cinco principales accionistas de Oculis Holding AG son: Mr. Martijn Kleijwegt
¿Cuántas instituciones poseen acciones de Oculis Holding AG (OCS)?
A fecha de 2026Q1, 72 instituciones poseen acciones de Oculis Holding AG, con un valor de mercado combinado de aproximadamente 27.88M, lo que representa el 54.68% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 2538023.00.